Giuseppe Delogu

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

M. Piras, M. Steri, V. Orrù, 2024, Frontiers in Immunology.

Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis

Dimitrios Tsitsipatis, M. Muroni, I. R. Zarbo, 2024, Cells.